Global Pneumococcal Vaccines Market Insights, Forecast to 2025

Table of Contents

1 Study Coverage

• 1.1 Pneumococcal Vaccines Product
• 1.2 Market Segments
• 1.3 Key Manufacturers Covered
• 1.4 Market by Type
  • 1.4.1 Global Pneumococcal Vaccines Market Size Growth Rate by Product
  • 1.4.2 PPSV 23
  • 1.4.3 PCV 7/13
  • 1.4.4 PCV 10
• 1.5 Market by End User
  • 1.5.1 Global Pneumococcal Vaccines Market Size Growth Rate by End User
  • 1.5.2 For Infants
  • 1.5.3 For Children (2-10)
  • 1.5.4 For Person (10-64)
  • 1.5.5 For The Old (≥65)
• 1.6 Study Objectives
• 1.7 Years Considered

2 Executive Summary

• 2.1 Global Pneumococcal Vaccines Market Size
  • 2.1.1 Global Pneumococcal Vaccines Revenue 2014-2025
  • 2.1.2 Global Pneumococcal Vaccines Sales 2014-2025
• 2.2 Pneumococcal Vaccines Growth Rate by Regions
  • 2.2.1 Global Pneumococcal Vaccines Sales by Regions
  • 2.2.2 Global Pneumococcal Vaccines Revenue by Regions

3 Breakdown Data by Manufacturers

• 3.1 Pneumococcal Vaccines Sales by Manufacturers
  • 3.1.1 Pneumococcal Vaccines Sales by Manufacturers
  • 3.1.2 Pneumococcal Vaccines Sales Market Share by Manufacturers
  • 3.1.3 Global Pneumococcal Vaccines Market Concentration Ratio (CR5 and HHI)
• 3.2 Pneumococcal Vaccines Revenue by Manufacturers
  • 3.2.1 Pneumococcal Vaccines Revenue by Manufacturers (2014-2019)
  • 3.2.2 Pneumococcal Vaccines Revenue Share by Manufacturers (2014-2019)
• 3.3 Pneumococcal Vaccines Price by Manufacturers
• 3.4 Pneumococcal Vaccines Manufacturing Base Distribution, Product Types
  • 3.4.1 Pneumococcal Vaccines Manufacturers Manufacturing Base Distribution, Headquarters
  • 3.4.2 Manufacturers Pneumococcal Vaccines Product Type
  • 3.4.3 Date of International Manufacturers Enter into Pneumococcal Vaccines Market
• 3.5 Manufacturers Mergers & Acquisitions, Expansion Plans

4 Breakdown Data by Product

• 4.1 Global Pneumococcal Vaccines Sales by Product
• 4.2 Global Pneumococcal Vaccines Revenue by Product
• 4.3 Pneumococcal Vaccines Price by Product

5 Breakdown Data by End User

• 5.1 Overview
• 5.2 Global Pneumococcal Vaccines Breakdown Data by End User

6 North America

• 6.1 North America Pneumococcal Vaccines by Countries
  • 6.1.1 North America Pneumococcal Vaccines Sales by Countries
  • 6.1.2 North America Pneumococcal Vaccines Revenue by Countries
  • 6.1.3 United States
  • 6.1.4 Canada
  • 6.1.5 Mexico
• 6.2 North America Pneumococcal Vaccines by Product
• 6.3 North America Pneumococcal Vaccines by End User

7 Europe

• 7.1 Europe Pneumococcal Vaccines by Countries
  • 7.1.1 Europe Pneumococcal Vaccines Sales by Countries
  • 7.1.2 Europe Pneumococcal Vaccines Revenue by Countries
  • 7.1.3 Germany
  • 7.1.4 France
  • 7.1.5 UK
  • 7.1.6 Italy
  • 7.1.7 Russia
• 7.2 Europe Pneumococcal Vaccines by Product
• 7.3 Europe Pneumococcal Vaccines by End User

8 Asia Pacific

• 8.1 Asia Pacific Pneumococcal Vaccines by Countries
  • 8.1.1 Asia Pacific Pneumococcal Vaccines Sales by Countries
  • 8.1.2 Asia Pacific Pneumococcal Vaccines Revenue by Countries
  • 8.1.3 China
  • 8.1.4 Japan
  • 8.1.5 Korea
  • 8.1.6 India
  • 8.1.7 Australia
  • 8.1.8 Indonesia
  • 8.1.9 Malaysia
  • 8.1.10 Philippines
  • 8.1.11 Thailand
  • 8.1.12 Vietnam
  • 8.1.13 Singapore
• 8.2 Asia Pacific Pneumococcal Vaccines by Product
• 8.3 Asia Pacific Pneumococcal Vaccines by End User

9 Central & South America

• 9.1 Central & South America Pneumococcal Vaccines by Countries
  • 9.1.1 Central & South America Pneumococcal Vaccines Sales by Countries
  • 9.1.2 Central & South America Pneumococcal Vaccines Revenue by Countries
  • 9.1.3 Brazil
• 9.2 Central & South America Pneumococcal Vaccines by Product
• 9.3 Central & South America Pneumococcal Vaccines by End User

10 Middle East and Africa

• 10.1 Middle East and Africa Pneumococcal Vaccines by Countries
  • 10.1.1 Middle East and Africa Pneumococcal Vaccines Sales by Countries
  • 10.1.2 Middle East and Africa Pneumococcal Vaccines Revenue by Countries
  • 10.1.3 GCC Countries
  • 10.1.4 Turkey
  • 10.1.5 Egypt
  • 10.1.6 South Africa
• 10.2 Middle East and Africa Pneumococcal Vaccines by Product
• 10.3 Middle East and Africa Pneumococcal Vaccines by End User

11 Company Profiles

• 11.1 Pfizer
  • 11.1.1 Pfizer Company Details
  • 11.1.2 Company Business Overview
  • 11.1.3 Pfizer Pneumococcal Vaccines Sales, Revenue and Gross Margin (2014-2019)
  • 11.1.4 Pfizer Pneumococcal Vaccines Products Offered
  • 11.1.5 Pfizer Recent Development
• 11.2 Sanofi
  • 11.2.1 Sanofi Company Details
  • 11.2.2 Company Business Overview
  • 11.2.3 Sanofi Pneumococcal Vaccines Sales, Revenue and Gross Margin (2014-2019)
  • 11.2.4 Sanofi Pneumococcal Vaccines Products Offered
  • 11.2.5 Sanofi Recent Development
• 11.3 GSK
  • 11.3.1 GSK Company Details
  • 11.3.2 Company Business Overview
  • 11.3.3 GSK Pneumococcal Vaccines Sales, Revenue and Gross Margin (2014-2019)
  • 11.3.4 GSK Pneumococcal Vaccines Products Offered
  • 11.3.5 GSK Recent Development
• 11.4 Merck
  • 11.4.1 Merck Company Details
  • 11.4.2 Company Business Overview
  • 11.4.3 Merck Pneumococcal Vaccines Sales, Revenue and Gross Margin (2014-2019)
  • 11.4.4 Merck Pneumococcal Vaccines Products Offered
  • 11.4.5 Merck Recent Development
• 11.5 Eli Lilly
  • 11.5.1 Eli Lilly Company Details
  • 11.5.2 Company Business Overview
  • 11.5.3 Eli Lilly Pneumococcal Vaccines Sales, Revenue and Gross Margin (2014-2019)
  • 11.5.4 Eli Lilly Pneumococcal Vaccines Products Offered
  • 11.5.5 Eli Lilly Recent Development
• 11.6 AstraZeneca
  • 11.6.1 AstraZeneca Company Details
  • 11.6.2 Company Business Overview
  • 11.6.3 AstraZeneca Pneumococcal Vaccines Sales, Revenue and Gross Margin (2014-2019)
  • 11.6.4 AstraZeneca Pneumococcal Vaccines Products Offered
  • 11.6.5 AstraZeneca Recent Development
• 11.7 Abera
  • 11.7.1 Abera Company Details
  • 11.7.2 Company Business Overview
  • 11.7.3 Abera Pneumococcal Vaccines Sales, Revenue and Gross Margin (2014-2019)
  • 11.7.4 Abera Pneumococcal Vaccines Products Offered
  • 11.7.5 Abera Recent Development
• 11.8 S K Chemicals
  • 11.8.1 S K Chemicals Company Details
  • 11.8.2 Company Business Overview
  • 11.8.3 S K Chemicals Pneumococcal Vaccines Sales, Revenue and Gross Margin (2014-2019)
  • 11.8.4 S K Chemicals Pneumococcal Vaccines Products Offered
  • 11.8.5 S K Chemicals Recent Development
• 11.9 Beijing Minhai Biotechnology
  • 11.9.1 Beijing Minhai Biotechnology Company Details
  • 11.9.2 Company Business Overview
  • 11.9.3 Beijing Minhai Biotechnology Pneumococcal Vaccines Sales, Revenue and Gross Margin (2014-2019)
  • 11.9.4 Beijing Minhai Biotechnology Pneumococcal Vaccines Products Offered
  • 11.9.5 Beijing Minhai Biotechnology Recent Development
• 11.10 Baxter
  • 11.10.1 Baxter Company Details
  • 11.10.2 Company Business Overview
  • 11.10.3 Baxter Pneumococcal Vaccines Sales, Revenue and Gross Margin (2014-2019)
  • 11.10.4 Baxter Pneumococcal Vaccines Products Offered
  • 11.10.5 Baxter Recent Development
• 11.11 Biken
• 11.12 Celgene Corporation
• 11.13 Panacea Biotec
• 11.14 Serum Institute of India
• 11.15 Genentech
• 11.16 Genocea Biosciences
• 11.17 ImmunoBiology
• 11.18 Lupin
• 11.19 Nuron Biotech
• 11.20 Biogen
• 11.21 Valneva Austria
• 11.22 Sinovac

12 Future Forecast

• 12.1 Pneumococcal Vaccines Market Forecast by Regions
  • 12.1.1 Global Pneumococcal Vaccines Sales Forecast by Regions 2019-2025
  • 12.1.2 Global Pneumococcal Vaccines Revenue Forecast by Regions 2019-2025
• 12.2 Pneumococcal Vaccines Market Forecast by Product
  • 12.2.1 Global Pneumococcal Vaccines Sales Forecast by Product 2019-2025
  • 12.2.2 Global Pneumococcal Vaccines Revenue Forecast by Product 2019-2025
• 12.3 Pneumococcal Vaccines Market Forecast by End User
• 12.4 North America Pneumococcal Vaccines Forecast
• 12.5 Europe Pneumococcal Vaccines Forecast
• 12.6 Asia Pacific Pneumococcal Vaccines Forecast
• 12.7 Central & South America Pneumococcal Vaccines Forecast
• 12.8 Middle East and Africa Pneumococcal Vaccines Forecast

13 Market Opportunities, Challenges, Risks and Influences Factors Analysis

• 13.1 Market Opportunities and Drivers
• 13.2 Market Challenges
• 13.3 Market Risks/Restraints
• 13.4 Macroscopic Indicators

14 Value Chain and Sales Channels Analysis

• 14.1 Value Chain Analysis
• 14.2 Pneumococcal Vaccines Customers
• 14.3 Sales Channels Analysis
  • 14.3.1 Sales Channels
  • 14.3.2 Distributors

15 Research Findings and Conclusion

16 Appendix

• 16.1 Research Methodology
  • 16.1.1 Methodology/Research Approach
  • 16.1.2 Data Source
• 16.2 Author Details